At the upcoming “TIDES” conference in Las Vegas later this month, oligo manufacturers will discuss a range of opportunities and challenges related to the growing market for DNA and RNA therapeutics.
Oligonucleotide-based drugs continue to flow into developmental pipelines, and the relatively large numbers now being tested in humans and progressing through late-stage clinical studies have buoyed ...
MILFORD, Mass.--(BUSINESS WIRE)--Avecia Biotechnology Inc., a leader in therapeutic nucleic acid manufacturing and development services, and a new member of the Nitto Denko Corporation, today ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...
CINCINNATI & BERGISCH GLADBACH, Germany, Jul 05, 2010 (BUSINESS WIRE) -- Girindus announced today that it has won a contract to begin work on validation of a manufacturing process for an ...
Intellegens, a company applying machine learning (ML) to accelerate innovation in R&D, today announced that it has secured a £1.6m grant from Innovate UK, part of UK Research and Innovation (UKRI), to ...
Sigma-Aldrich's SAFC custom manufacturing business has received a license to Beckman Coulter's fast deprotection chemistry. According to SAFC, the deal covers Beckman's acetyl-protected cytidine DNA ...
TEDA TIANJIN, China , March 25, 2021 /PRNewswire/ -- Asymchem (stock code: 002821.SZ), is excited to announce a dedicated expansion of our API manufacturing facilities to provide clients with peptide ...
Unfortunately, no simple, reproducible, sensitive, and inexpensive analytical method exists to identify and quantify every protecting group that may remain in an antisense sample. High-performance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback